November 13, 2020
|
Progenity to Host Preeclampsia Virtual R&D Day on November 20, 2020
|
November 9, 2020
|
Progenity Provides Corporate Updates and Reports Third Quarter 2020 Financial Results
|
November 6, 2020
|
Progenity Announces Encouraging Preclinical Data Supporting the Potential of the Company’s Oral Drug Delivery System in Targeting the Colon
|
November 3, 2020
|
Progenity to Report Third Quarter 2020 Financial Results and Provide Corporate Update
|
October 29, 2020
|
Progenity Announces Successful Achievement of its Preeclampsia Test Analytical Verification Milestone
|
October 27, 2020
|
Progenity Presents Data from Award-Winning Abstract on Novel Ingestible Lab-in-a-Capsule at American College of Gastroenterology (ACG) 2020 Virtual Annual Meeting
|
October 9, 2020
|
Progenity to Present Precision Medicine Abstracts at American College of Gastroenterology (ACG) Virtual Annual Meeting in October
|
October 1, 2020
|
Progenity Supports the Preeclampsia Foundation Call to Action to Accelerate Development and Adoption of Biomarker Tests for Preeclampsia
|
September 18, 2020
|
Progenity Announces Addition to Russell 2000® Index
|
September 2, 2020
|
Progenity to Participate in Two Upcoming Investor Conferences
|